About the Rome IV Criteria for Functional Constipation
Two or more of six items, and then two exclusions that decide everything. The six are straining, hard or lumpy stools, incomplete evacuation, anorectal obstruction, manual manoeuvres — each in more than a quarter of defecations — and fewer than three spontaneous bowel movements a week. Loose stools must be rare without laxatives, and criteria for irritable bowel syndrome must NOT be met. That last exclusion is where most misclassification happens: a patient with abdominal pain related to defecation has IBS with constipation, not functional constipation, however constipated they are.
Formula
Functional constipation = timing AND (≥ 2 of 6 symptom items) AND loose stools rare without laxatives AND NOT IBS- ≥ 2 of 6
- Two is the threshold, not one. Each item is defined as occurring in more than 25% of defecations, except the frequency item which is fewer than three spontaneous bowel movements a week.
- NOT IBS
- A hard exclusion. Rome IV does not permit a patient to hold both diagnoses simultaneously, unlike the overlap it explicitly allows between functional dyspepsia and IBS.
- The symptom items are proportions of defecations, not weekly counts — 'more than a quarter of the time' rather than 'more than twice a week'.
- Spontaneous bowel movements means without laxatives. This is why a patient on regular laxatives can still meet the frequency item.
- Rome IV notes that for research studies, patients meeting criteria for opioid-induced constipation should not also be given a diagnosis of functional constipation — but acknowledges the two overlap in clinical practice.
- Functional constipation and functional defecation disorders are not alternatives: the latter requires the former (or IBS-C) as a prerequisite.
Interpreting the result
Meeting the criteria establishes chronic constipation as a functional disorder, and the immediate next question is which kind. If the patient endorses incomplete evacuation, anorectal obstruction or manual manoeuvres, arrange anorectal physiology and a balloon expulsion test before escalating laxatives — those items point toward impaired evacuation, and biofeedback rather than more laxative is the treatment. Review the drug chart for constipating agents, particularly opioids: where an opioid is involved, opioid-induced constipation is the better-fitting diagnosis and it has its own licensed treatments. Where criteria are not met because IBS criteria are, follow the IBS pathway — the practical difference is that several drugs are licensed for one indication and not the other, and the trial evidence is separate. A failure on symptom count alone, with only one item met, generally means the constipation is milder than the criteria are designed to capture rather than that something has been missed.
| Score | Band | What it means | Action |
|---|---|---|---|
| ≥ 2 items, both exclusions met | Functional constipation | Chronic constipation meeting Rome IV criteria, with IBS excluded | Ask whether this is an evacuation disorder — incomplete evacuation, obstruction or manual manoeuvres should prompt anorectal testing before laxative escalation |
| IBS criteria met | Criteria not met — IBS with constipation | Abdominal pain related to defecation makes this IBS-C rather than functional constipation | Use the Rome IV IBS pathway; the licensed treatments differ |
| Fewer than 2 items | Criteria not met | Below the symptom threshold Rome IV sets | Reassess if symptoms progress; consider whether an opioid or another constipating drug is responsible |
What the Functional Constipation needs (9 inputs)
- Timing
- Criteria fulfilled for the last three months with symptom onset at least six months before diagnosis.
- Straining in more than 25% of defecations
- One of six symptom items, two of which are required. Note the proportion — it is a fraction of defecations, not a frequency per week.
- Lumpy or hard stools (Bristol 1–2) in more than 25% of defecations
- Bristol types 1 and 2 specifically. Using a general impression of 'hard' rather than the scale is the commonest source of imprecision here.
- Sensation of incomplete evacuation in more than 25% of defecations
- This item, and the obstruction and manual-manoeuvre items, are the ones that should raise the question of a functional defecation disorder.
- Sensation of anorectal obstruction or blockage in more than 25% of defecations
- Suggests impaired evacuation rather than slow transit, and is worth acting on rather than simply recording.
- Manual manoeuvres in more than 25% of defecations
- Digital evacuation or support of the pelvic floor. Patients rarely volunteer this and are often embarrassed by it — it needs asking about directly.
- Fewer than three spontaneous bowel movements per week
- Spontaneous means without laxatives. A patient having daily bowel movements only on laxatives does not fail this item.
- Loose stools rarely present without laxatives
- Separates functional constipation from a mixed bowel pattern. Frequent loose stools off laxatives points elsewhere.
- Insufficient criteria for irritable bowel syndrome
- The decisive exclusion. IBS requires recurrent abdominal pain at least one day a week related to defecation or to a change in stool frequency or form; where that is present, the diagnosis is IBS with constipation.
What it returns
- Criteria met or not met
- Requires two or more symptom items plus both exclusions and the timing rule.
- Number of symptom items met
- Reported out of six, so it is clear whether a failure is on symptom count or on an exclusion.
How it is calculated
The six items were chosen to capture constipation as patients experience it rather than as a stool-frequency count, which is why five of them describe the act of defecation and only one counts bowel movements. That reflects a repeated finding in this field: patients complaining of constipation frequently have normal stool frequency, and what troubles them is straining, incompleteness or the need to assist evacuation manually. The two-item threshold is a consensus judgement about where troublesome becomes pathological. The IBS exclusion is structural rather than mechanistic — Rome IV places abdominal pain at the centre of IBS and treats its presence as defining, so the same bowel habit with and without pain becomes two different disorders. That is a taxonomic decision with real consequences for which trials a patient's treatment is based on.
Facts & figures
| Item | Threshold | Implication |
|---|---|---|
| Straining | > 25% of defecations | Non-specific |
| Lumpy or hard stools (Bristol 1–2) | > 25% of defecations | Suggests slow transit |
| Sensation of incomplete evacuation | > 25% of defecations | Raises the question of an evacuation disorder |
| Sensation of anorectal obstruction | > 25% of defecations | Raises the question of an evacuation disorder |
| Manual manoeuvres | > 25% of defecations | Strongly suggests an evacuation disorder — ask directly, patients do not volunteer it |
| Fewer than 3 spontaneous bowel movements | Per week | The only frequency item; 'spontaneous' means without laxatives |
Three of the six point toward impaired evacuation rather than slow transit. Recording them without acting on them is the commonest missed opportunity in refractory constipation.
Evidence
Derivation — Rome Foundation, bowel disorders committee
2016Consensus criteria from the Rome IV bowel disorders committee, published in Gastroenterology in 2016 alongside the revised IBS criteria.
Consensus-derived. Rome IV retained the six-item structure and the two-item threshold, and reinforced the mutual exclusivity with IBS — a patient meeting IBS criteria cannot simultaneously carry a functional constipation diagnosis.
Guideline adoption — AGA/ACG 2023
2023Joint clinical practice guideline of the American Gastroenterological Association and the American College of Gastroenterology on the pharmacological management of chronic idiopathic constipation.
Sets out the evidence for osmotic and stimulant laxatives, secretagogues and prokinetics in this population, and treats chronic idiopathic constipation and Rome-defined functional constipation as the same clinical entity.
Anorectal assessment — ACG 2021
2021ACG clinical guideline on the management of benign anorectal disorders, covering evaluation for defecatory dysfunction in constipated patients.
Recommends anorectal manometry and balloon expulsion testing in patients with constipation not responding to conservative measures, on the basis that impaired evacuation is common and specifically treatable with biofeedback.
How it compares
Functional Constipation vs Rome IV criteria for IBS
Mutually exclusive by design — abdominal pain related to defecation makes it IBS with constipation, and the boundary is taxonomic rather than mechanistic.
Rome IV requires that functional constipation criteria include 'insufficient criteria for irritable bowel syndrome', so the two cannot be held simultaneously. The separator is recurrent abdominal pain at least one day a week related to defecation or to a change in stool frequency or form. Physiologically the disorders are hard to distinguish, patients move between them over time, and the treatments overlap substantially — the boundary exists mainly because trials and drug licences follow one definition or the other. Practically, check for pain explicitly rather than assuming, since a constipated patient will often not mention pain unless asked.
Functional Constipation vs Functional defecation disorders
Not an alternative but a next step — a functional defecation disorder requires functional constipation or IBS-C first, and it is what laxative-refractory constipation frequently turns out to be.
The Rome IV defecation disorder criteria take functional constipation or IBS with constipation as a prerequisite, then add two of three objective tests demonstrating impaired evacuation. This matters because the treatments diverge completely: a transit problem responds to laxatives and secretagogues, while a coordination problem responds to biofeedback and does not respond to laxatives at all. The symptom items in the functional constipation criteria that should prompt the question are incomplete evacuation, anorectal obstruction and manual manoeuvres.
Functional Constipation vs Opioid-induced constipation
Same six symptom items, different trigger — and Rome IV asks that research studies keep them apart while accepting they overlap in practice.
Opioid-induced constipation uses the identical six items but requires new or worsening constipation on initiating, changing or increasing opioid therapy, and drops the three-month and six-month timing requirements entirely. The distinction matters clinically because peripherally acting mu-opioid receptor antagonists are licensed for opioid-induced constipation and target its mechanism directly without reversing analgesia. Rome IV's footnote is candid that separating the two is difficult when a patient on long-term opioids also has other reasons to be constipated.
Pearls & pitfalls
- The IBS exclusion decides the diagnosis. Abdominal pain related to defecation makes it IBS with constipation, and Rome IV does not allow both labels at once.
- The items are proportions of defecations, not weekly frequencies. 'More than a quarter of the time' is the threshold.
- 'Spontaneous' bowel movements means without laxatives — a patient going daily on macrogol can still meet the frequency item.
- Ask directly about manual manoeuvres. Patients almost never volunteer digital evacuation or pelvic floor support, and it is the item most predictive of an evacuation disorder.
- Incomplete evacuation, obstruction and manual manoeuvres should trigger anorectal testing, not more laxative.
- Use the Bristol scale for the stool item rather than a general impression of hardness.
- Where opioids are involved, opioid-induced constipation is the better diagnosis and has its own licensed treatments. Rome IV keeps them separate for research while acknowledging clinical overlap.
- A functional defecation disorder cannot be diagnosed without this label or IBS-C first — it is a prerequisite, not an alternative.
- Alarm features — rectal bleeding, weight loss, anaemia, new onset over 50, family history of colorectal cancer — are outside the criteria and must be addressed independently.
Critical actions
- Establish whether IBS criteria are met before applying this label, since abdominal pain related to defecation changes the diagnosis.
- Ask specifically about incomplete evacuation, anorectal obstruction and manual manoeuvres — the three items that point to impaired evacuation.
- Review the drug chart for constipating agents, particularly opioids, calcium channel blockers, anticholinergics and iron.
- Address alarm features independently of the criteria.
- In constipation not responding to conservative measures, arrange anorectal manometry and a balloon expulsion test rather than escalating laxatives indefinitely.
- Optimise fibre and fluid, then use an osmotic laxative first-line, adding a stimulant or a secretagogue as needed per guideline.
- Reassess the diagnosis if the pattern changes — patients migrate between functional constipation and IBS-C over time.
Why this score exists
The committee's decision to keep functional constipation and IBS with constipation mutually exclusive is the most consequential and the most argued-over feature of these criteria. Physiologically the two are hard to separate — patients move between them over time, transit studies do not distinguish them reliably, and the same treatments often work in both. The justification is practical rather than mechanistic: trials recruit to one definition or the other, drug licences follow the trials, and allowing patients to hold both labels would make the evidence base uninterpretable. The committee was explicit that this is a research-driven boundary. In clinical practice the more useful question is usually not which of the two labels applies but whether the constipation is a transit problem or an evacuation problem, and the Rome criteria do not answer that — which is why the defecation disorder criteria exist separately.
About the creator
First author, Rome IV bowel disorders committee
Chaired the committee that wrote the Rome IV criteria for the functional bowel disorders.
Co-author, Rome IV bowel disorders committee
Co-authored the bowel disorders chapter including the functional constipation criteria.
Co-author; functional bowel disorder physiology
Contributed to the physiological framework underlying the bowel disorder definitions.
Limitations
- The IBS exclusion is taxonomic rather than mechanistic, and patients move between the two categories over time, so the label is less stable than it appears.
- The criteria describe symptoms but say nothing about mechanism — slow transit, normal transit and evacuation disorders all meet them identically.
- The two-item threshold and the 25% proportions are consensus judgements without empirical derivation.
- Symptom proportions require patients to estimate across many defecations, which is unreliable without a diary.
- The two-of-six threshold is a consensus convention; no study has demonstrated that patients meeting two items differ meaningfully from those meeting one.
- The relationship with opioid-induced constipation is acknowledged as blurred in the criteria's own footnote.
- Says nothing about severity, and patients meeting criteria range from mildly inconvenienced to severely disabled.
- Does not address the substantial psychological comorbidity or the quality-of-life impact that drives much of the burden.
If you are the patient
Functional constipation is a diagnosis based on how your bowels behave rather than on a test result. Doctors look for at least two of six things, each happening more than a quarter of the time: straining, hard or lumpy stools, feeling you have not fully emptied, feeling blocked, needing to help with a finger or by pressing, or opening your bowels fewer than three times a week without laxatives. Two other things must also be true — loose stools should be uncommon when you are not taking laxatives, and you should not fit the pattern for irritable bowel syndrome, which is diagnosed when tummy pain linked to opening your bowels is a main feature. There is one thing genuinely worth raising with your doctor. If you often feel you have not fully emptied, feel blocked, or need to use a finger to help, that can mean the muscles around the back passage are not coordinating properly rather than the bowel being slow. That is a different problem, it is common in people whose constipation has not responded to laxatives, and laxatives will not fix it — but a treatment called biofeedback, which retrains those muscles, works well. It is only found by asking for specific tests, so mentioning those symptoms directly is worthwhile. Many people feel awkward describing them; they are common and your doctor will have heard them many times.
Frequently asked questions
What are the Rome IV criteria for functional constipation?#
Two or more of: straining, lumpy or hard stools (Bristol 1–2), sensation of incomplete evacuation, sensation of anorectal obstruction, or manual manoeuvres — each in more than 25% of defecations — or fewer than three spontaneous bowel movements per week. Plus loose stools rarely present without laxatives, and insufficient criteria for IBS. All fulfilled for three months with onset at least six months earlier.
What is the difference between functional constipation and IBS-C?#
Abdominal pain. IBS requires recurrent abdominal pain at least one day a week related to defecation or to a change in stool frequency or form; functional constipation explicitly requires that IBS criteria are not met. Rome IV does not allow both diagnoses simultaneously. The distinction is largely taxonomic — patients migrate between the categories — but it determines which trial evidence and which drug licences apply.
Do the symptom items mean per week or per bowel movement?#
Per defecation. Five of the six items are proportions — occurring in more than 25% of defecations — rather than weekly counts. Only the sixth item, fewer than three spontaneous bowel movements per week, is a frequency. Reading the proportions as frequencies is a common error and misclassifies patients in both directions.
What does 'spontaneous bowel movement' mean?#
A bowel movement occurring without laxatives. This is why a patient opening their bowels daily on macrogol can still meet the frequency item — the count is of unassisted bowel movements. It is a distinction worth making explicitly when taking the history, since patients usually report their treated frequency.
When should constipation be investigated for a defecation disorder?#
When the patient endorses incomplete evacuation, a sensation of anorectal blockage, or the need for manual manoeuvres — and certainly when constipation has not responded to conservative treatment. Anorectal manometry with a balloon expulsion test is the assessment. Around half of patients with refractory constipation have impaired evacuation, which laxatives do not fix and biofeedback does.
Can you have functional constipation and opioid-induced constipation together?#
Rome IV asks that research studies not give both diagnoses, because separating opioid effects from other causes is difficult — but it explicitly acknowledges that the two conditions may overlap in clinical practice. Where an opioid is involved, opioid-induced constipation is usually the more useful label, since peripherally acting mu-opioid receptor antagonists target that mechanism directly.
Is functional constipation the same as chronic idiopathic constipation?#
In practice yes. The AGA and ACG guideline on chronic idiopathic constipation treats it as the same clinical entity as Rome-defined functional constipation, and the trial evidence for laxatives, secretagogues and prokinetics is drawn from populations defined either way. The Rome label is the more precise one; 'chronic idiopathic constipation' is how the same patients are described in the treatment literature.
Do alarm features affect the Rome IV criteria?#
They sit outside them entirely. Rome IV defines the functional disorder and assumes organic disease has been considered separately. Rectal bleeding, weight loss, iron deficiency anaemia, new onset over 50 and a family history of colorectal cancer all require investigation regardless of how well the criteria fit, and a functional label should never be used to defer that.
References
Original / primary reference
Clinical practice guidelines
- Chang L, Chey WD, Imdad A, et al. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. Gastroenterology. 2023;164(7):1086-1106.
- Wald A, Bharucha AE, Limketkai B, et al. ACG Clinical Guidelines: Management of Benign Anorectal Disorders. Am J Gastroenterol. 2021;116(10):1987-2008.